1.33
price down icon4.32%   -0.06
after-market Handel nachbörslich: 1.34 0.01 +0.75%
loading
Schlusskurs vom Vortag:
$1.39
Offen:
$1.38
24-Stunden-Volumen:
339.14K
Relative Volume:
0.55
Marktkapitalisierung:
$1.96M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.1334
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
-24.00%
1M Leistung:
-35.75%
6M Leistung:
-67.56%
1J Leistung:
-89.54%
1-Tages-Spanne:
Value
$1.26
$1.3826
1-Wochen-Bereich:
Value
$1.26
$1.7548
52-Wochen-Spanne:
Value
$1.26
$12.95

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Firmenname
60 Degrees Pharmaceuticals Inc
Name
Telefon
202-327-5422
Name
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
SXTP's Discussions on Twitter

Vergleichen Sie SXTP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
1.33 2.58M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant stockFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

60 Degrees Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastFree Trend-Following Techniques - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives 60 Degrees Pharmaceuticals Inc. Equity Warrant stock priceBreakthrough capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is 60 Degrees Pharmaceuticals Inc. a good long term investmentTremendous wealth creation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about 60 Degrees Pharmaceuticals Inc. stockHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives 60 Degrees Pharmaceuticals Inc. stock priceConsistently high yield - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a good long term investmentExceptional market performance - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

60 Degrees Pharmaceuticals Inc. Stock Analysis and ForecastOutstanding capital appreciation - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Will 60 Degrees Pharmaceuticals Inc. stock benefit from interest rate changesHigh Return Stock Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

60 Degrees Pharmaceuticals Secures $5M in Recent Offering - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

How 60 Degrees Pharmaceuticals Inc. stock reacts to Fed policy changesFree Deep Market Trend Analysis - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

What risks could impact 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performanceWealth Building Stock Portfolio - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

60 Degrees Pharmaceuticals to study tafenoquine against Lyme disease By Investing.com - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

60 Degrees Pharmaceuticals Initiates Study on Tafenoquine's Efficacy Against Lyme Disease and Bartonella Pathogens - Nasdaq

Jul 17, 2025
pulisher
Jul 17, 2025

60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria - The Manila Times

Jul 17, 2025
pulisher
Jul 17, 2025

60 Degrees Pharmaceuticals to study tafenoquine against Lyme disease - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

Major Breakthrough: Anti-Malaria Drug Tafenoquine Being Tested for Lyme Disease Treatment - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals' Warrant Gambit: Balancing Liquidity and Longevity - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals closes $5 million public offering By Investing.com - Investing.com Nigeria

Jul 16, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals closes $5 million public offering - Investing.com Australia

Jul 16, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals Secures $5 Million in Public Offering - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering - Stock Titan

Jul 16, 2025
pulisher
Jul 16, 2025

Form 424B4 60 DEGREES PHARMACEUTICA - StreetInsider

Jul 16, 2025

Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):